MONTI, Maria Chiara
 Distribuzione geografica
Continente #
AS - Asia 8.877
NA - Nord America 6.143
EU - Europa 5.097
SA - Sud America 1.019
Continente sconosciuto - Info sul continente non disponibili 351
AF - Africa 174
OC - Oceania 13
Totale 21.674
Nazione #
US - Stati Uniti d'America 5.824
SG - Singapore 3.839
RU - Federazione Russa 2.208
CN - Cina 2.153
IT - Italia 1.528
VN - Vietnam 1.237
BR - Brasile 809
HK - Hong Kong 574
DE - Germania 330
FR - Francia 295
BD - Bangladesh 231
KR - Corea 202
CA - Canada 173
JP - Giappone 155
GB - Regno Unito 140
IN - India 139
NL - Olanda 129
FI - Finlandia 119
AR - Argentina 81
MX - Messico 72
IE - Irlanda 62
UA - Ucraina 59
ZA - Sudafrica 56
AT - Austria 43
IQ - Iraq 43
PL - Polonia 39
EC - Ecuador 37
PH - Filippine 37
CI - Costa d'Avorio 31
ID - Indonesia 31
TH - Thailandia 30
ES - Italia 29
SE - Svezia 27
PK - Pakistan 25
TR - Turchia 24
TW - Taiwan 24
CO - Colombia 22
UZ - Uzbekistan 21
VE - Venezuela 18
CL - Cile 17
MA - Marocco 17
PY - Paraguay 16
NP - Nepal 15
BE - Belgio 13
CR - Costa Rica 13
LT - Lituania 12
DZ - Algeria 10
JM - Giamaica 10
KE - Kenya 10
LU - Lussemburgo 10
MY - Malesia 10
PE - Perù 10
SA - Arabia Saudita 10
TN - Tunisia 10
JO - Giordania 9
AZ - Azerbaigian 8
IL - Israele 8
AU - Australia 7
OM - Oman 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
HN - Honduras 6
KZ - Kazakistan 6
PT - Portogallo 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
EG - Egitto 5
LB - Libano 5
NI - Nicaragua 5
PA - Panama 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
GA - Gabon 4
HR - Croazia 4
KG - Kirghizistan 4
PR - Porto Rico 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
BB - Barbados 3
DK - Danimarca 3
EU - Europa 3
GE - Georgia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NG - Nigeria 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
BZ - Belize 2
CM - Camerun 2
DJ - Gibuti 2
EE - Estonia 2
GP - Guadalupe 2
KH - Cambogia 2
KW - Kuwait 2
ML - Mali 2
Totale 21.274
Città #
Singapore 2.033
San Jose 1.273
Hefei 999
Moscow 576
Ashburn 565
Hong Kong 548
Naples 526
Beijing 378
Ho Chi Minh City 334
Santa Clara 330
Hanoi 278
Los Angeles 198
Council Bluffs 189
Lauterbourg 187
Chandler 184
Seoul 183
The Dalles 157
Tokyo 134
Munich 114
New York 110
São Paulo 96
Dallas 89
Buffalo 82
Redondo Beach 79
Phoenix 78
Napoli 65
Rome 59
Boston 56
Millbury 56
Nuremberg 56
Amsterdam 52
Boardman 50
Haiphong 49
Orem 49
Da Nang 48
Nanjing 46
Princeton 44
Atlanta 43
Frankfurt am Main 42
Toronto 42
Milan 40
Brooklyn 37
Jacksonville 37
Dong Ket 36
Kronberg 35
Seattle 35
Warsaw 33
Mexico City 32
Des Moines 31
Lappeenranta 29
Montreal 29
Denver 27
London 27
San Francisco 27
Chicago 26
Torre del Greco 26
Helsinki 25
Johannesburg 24
Chennai 23
Perugia 22
Falkenstein 21
Houston 21
Turku 21
Wilmington 21
Bologna 20
Fisciano 20
Kochi 20
Rio de Janeiro 20
Biên Hòa 19
Hải Dương 19
Salerno 19
Tashkent 19
Ercolano 18
Lawrence 18
Brasília 17
Vienna 17
Belo Horizonte 16
Catania 16
Manchester 16
Nanchang 16
Ottawa 16
Pune 16
Bangkok 15
Stockholm 15
Turin 15
Curitiba 14
Poplar 14
Rochdale 14
Thái Nguyên 14
Tianjin 14
Washington 14
Woodbridge 14
Baghdad 13
Thái Bình 13
Bắc Giang 12
Querétaro 12
Quito 12
San José 12
Xi'an 12
Angri 11
Totale 11.724
Nome #
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 248
Natural and semisynthetic bile acids as Leukemia Inhibitory Factor (LIF) receptor antagonists 242
PROTEOMICS-AIDED INSIGHT TO DISCLOSE NATURAL PRODUCTS CELLULAR TARGETS 195
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4-/- Mice 185
Boswellia serrata: a rich source of triterpenes acting as antagonists of the leukemia inhibitory factor receptor 182
Design, synthesis and pharmacological characterization of novel potent nonsteroidal agonists of the farnesoid X receptor 182
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 182
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury 176
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 174
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 172
Theonella swinhoei as a source of anti-inflammatory cyclopeptides 172
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 162
Exploring Boswellia serrata Triterpenes: A New Frontier in Leukemia Inhibitory Factor Receptor Modulation 160
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 158
Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity 158
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 154
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 152
Synthesis of new isoxazole derivatives as fxr agonists with improved pharmacokinetic properties 151
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents 150
Perthamides C and D, two new potent anti-inflammatory cyclopeptides from a Solomon Lithistid sponge Theonella swinhoei 148
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 146
Mercator Fellow to GRK2158-Universität Düsseldorf 144
Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones 142
Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1 141
Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2 140
In cell scalaradial interactome profiling using a bio-orthogonal clickable probe 139
Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists 139
Involvement of 3′,5′-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular tone 139
The molecular mechanism of human group IIA phospholipase A2 inactivation by bolinaquinone 138
Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis 135
Dissecting common and divergent molecular pathways involved in plant cell response to abrupt or gradual water deficit in potato 135
Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury 135
β-Boswellic acid, a bioactive substance used in food supplements, inhibits protein synthesis by targeting the ribosomal machinery 133
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 131
Sex Differences in Sphingosine-1-Phosphate Levels Are Dependent on Ceramide Synthase 1 and Ceramidase in Lung Physiology and Tumor Conditions 131
Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor 131
Synthesis of new bile acids derivatives as selective FXR/GPBAR1 ligands 130
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 129
Proteomic analysis of Zn depletion/repletion in the hormone-secreting thyroid follicular cell line FRTL-5 127
Introduction of Nonacidic Side Chains on 6-Ethylcholane Scaffolds in the Identification of Potent Bile Acid Receptor Agonists with Improved Pharmacokinetic Properties 127
Copper binds the carboxy-terminus of trefoil protein 1 (TFF1), favoring its homodimerization and motogenic activity 126
Copper-binding activity of Trefoil factor 1 (TFF1): a new perspective in the study of the multifunctional roles of TFFs 126
Intracellular sphingosine-1-phosphate receptor 3 contributes to lung tumor cell proliferation 125
Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-κB and other unidentified targets 125
Modification on Ursodeoxycholic Acid (UDCA) Scaffold. Discovery of Bile Acid Derivatives As Selective Agonists of Cell-Surface G-Protein Coupled Bile Acid Receptor 1 (GP-BAR1) 125
Speculation on 6-ethylcholane scaffold in the discovery of novel FXR and GPBAR1 ligands. 125
Results and Perspectives on Anti-inflammatory Marine Natural Products 124
A label free chemoproteomic-based platform to disclose cannabidiol molecular mechanism of action on chronic myelogenous leukemia cancer cells 124
Drug affinity-responsive target stability unveils filamins as biological targets for artemetin, an anti-cancer flavonoid 124
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease 124
Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 binders 124
New insights on the interaction mechanism between tau protein and oleocanthal, an extra-virgin olive-oil bioactive component 123
Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids 123
The Binding Mode of Petrosaspongiolide M to the Human Group IIA Phospholipase A2: Exploring the Role of Covalent and Noncovalent Interactions in the Inhibition Process 122
Investigation around the Oxadiazole Core in the Discovery of a New Chemotype of Potent and Selective FXR Antagonists 122
Multi-target profile of oleocanthal, an extra-virgin olive oil component 121
RETRACTED: Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2 121
Sphingosine-1-phosphate contributes to TLR9-induced TNF-α release in lung tumor cells 120
Perthamide C Inhibits eNOS and iNOS Expression and Has Immunomodulating Activity In Vivo 120
Biomolecular Recognition with Calixarene Derivatives by a MS-Based Chemoproteomic Approach 119
Further Insights on the Structural Aspects of PLA2 Inhibition by g-hydroxybutenolide-containing Natural Products: a Comparative Study on Petrosaspongiolides M-R 119
Synthesis, functional proteomics and biological evaluation of new 5-pyrazolyl ureas as potential anti-angiogenic compounds 117
Trefoil Factor 1 is involved in gastric cell copper homeostasis 117
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4 −/− mice 116
Copper promotes TFF1-mediated Helicobacter pylori colonization 116
Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor 116
N-Formyl-7-amino-11-cycloamphilectene, a marine sponge metabolite, binds to tubulin and modulates microtubule depolymerization 116
Label-Free Quantitative Proteomics to Explore the Action Mechanism of the Pharmaceutical-Grade Triticum vulgare Extract in Speeding up Keratinocyte Healing 116
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 116
Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosis 115
Genomics-Metabolomics Profiling Disclosed Marine Vibrio spartinae 3.6 as a Producer of a New Branched Side Chain Prodigiosin 115
Modulation of Proteasome Machinery by Natural and Synthetic Analogues of the Marine Bioactive Compound Petrosaspongiolide M 114
The Inactivation Mechanism of Human Group IIA Phospholipase A2by Scalaradial 114
A Proteomic Platform Unveils the Brain Glycogen Phosphorylase as a Potential Therapeutic Target for Glioblastoma Multiforme 114
A multidisciplinary functional proteomics-aided strategy as a tool for the profiling of a novel cytotoxic thiadiazolopyrimidone 113
Modulation of Tau Protein Fibrillization by Oleocanthal 113
Triterpenes from Boswellia serrata as a New Chemotype of Leukaemia Inhibitory Factor Receptor Antagonists. 113
Quantitative proteomics discloses monacolin K-induced alterations in triple-negative breast cancer cell proteomes and phosphoproteomes 112
Effects of Petrosapongiolide R on the Surface Topology of bee venom PLA2: a Limited Proteolysis and Mass Spectrometry Analysis 112
Biomolecular Fishing for Calixarene Partners by a Chemoproteomic Approach 111
Chemical Proteomics Discloses Petrosapongiolide M, an Anti-Inflammatory Marine Sesterterpene, as a Proteasome Inhibitor 111
Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative 111
Transcriptome analysis of dual FXR and GPBAR1 agonism in rodent model of NASH reveals modulation of lipid droplets formation 111
An oenothera biennis cell cultures extract endowed with skin anti-ageing activity improves cell mechanical properties 110
Theonellasterol: a highly selective FXR antagonist that protects against liver injury in cholestasis 109
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 108
Structure and Function of Bacterial Kid-Kis and Related Toxin-Antitoxin Systems 108
Proteasome as a new target for bio-inspired benzo[k,l]xanthene lignans 108
Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance 108
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 108
Navigation in bile acid chemical space: discovery of novel FXR and GPBAR1 ligands 108
Identification of trombospondin-1 as a novel amelogenin interactor by functional proteomics 108
Chemical proteomics, a powerful tool in drug-target discovery 107
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy 107
Copper binding activity of trefoil factor 1 (TFF1): a new perspective in the study of multifunctional roles of TFFs factors 107
Targeting bile acid receptors: discovery of a potent and selective Farnesoid X receptor agonist as a new lead in the pharmacological approach to liver diseases 106
Intestinal microbiota, bile acids activated receptors and metabolism: development of novel therapeutic targets in the treatment of steato-hepatitis (NASH) 105
In Cell Interactome of Oleocanthal, an Extra Virgin Olive Oil Bioactive Component 105
Structure-Based Design, Synthesis and Preliminary Anti-inflammatory Activity of Bolinaquinone Analogues 104
Mechanistic insights on petrosaspongiolide M inhibitory effects on immunoproteasome and autophagy 104
Totale 13.126
Categoria #
all - tutte 67.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.655


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022330 0 0 0 3 5 17 8 18 67 15 51 146
2022/2023459 65 36 13 38 47 53 17 44 77 29 38 2
2023/2024771 16 45 38 23 17 34 84 75 29 29 228 153
2024/20255.835 288 376 78 107 157 286 609 419 377 628 1.973 537
2025/202612.150 1.242 1.410 1.470 1.442 1.582 436 943 749 1.320 663 412 481
2026/20271.399 329 458 504 108 0 0 0 0 0 0 0 0
Totale 21.674